Convert Pharmaceuticals is a preclinical-stage research and development company, building a proprietary drug pipeline that exploits the presence of hypoxia in tumors.
View Top Employees from Convert PharmaceuticalsWebsite | http://www.convertpharma.com |
Revenue | $5.5 million |
Employees | 3 (0 on RocketReach) |
Founded | 2017 |
Address | 6 Quai Banning, Liege, Wallonia 4000, BE |
Phone | (322) 880-6730 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Convert Pharmaceuticals employee's phone or email?
The Convert Pharmaceuticals annual revenue was $5.5 million in 2024.
Convert Pharmaceuticals is based in Liege, Wallonia.
The NAICS codes for Convert Pharmaceuticals are [325, 32541, 32, 3254].
The SIC codes for Convert Pharmaceuticals are [283, 28].